uniQure (QURE) FCF Margin Growth (3y) (2019 - 2026)
Powered by 
Analysis
uniQure (QURE) FCF Margin Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | -63,107.00 |
| 3 | Iovance Biotherapeutics | 3.80 Bn | 3.50 Bn | 55.72 Mn | 4.25 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 12,129.00 |
| 5 | uniQure | 3.04 Bn | 3.04 Bn | 5.49 Mn | 190,033.00 |
| 6 | Beam Therapeutics | 2.64 Bn | 2.64 Bn | - | -1.35 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 86,497.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 10,262.00 |
| 9 | Vericel | 1.98 Bn | 1.82 Bn | 56.40 Mn | 371.00 |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 190,033.00 |
| Mar 31, 2026 | 43,687.00 |
| Dec 31, 2025 | -133,711.00 |
| Sep 30, 2025 | 321,473.00 |
| Jun 30, 2025 | 331,274.00 |
| Mar 31, 2025 | -116,112.00 |
| Dec 31, 2024 | -92,513.00 |
| Sep 30, 2024 | 78,890.00 |
| Jun 30, 2024 | -38,872.00 |
| Mar 31, 2024 | 920,318.00 |
| Dec 31, 2023 | -65,384.00 |
| Sep 30, 2023 | 470,127.00 |
| Jun 30, 2023 | -33,211.00 |
| Mar 31, 2023 | 3.08 Mn |
| Dec 31, 2022 | 100,737.00 |
| Sep 30, 2022 | -133,520.00 |
| Jun 30, 2022 | -304,849.00 |
| Mar 31, 2022 | 68,667.00 |
| Dec 31, 2021 | 106,781.00 |
| Sep 30, 2021 | -174,933.00 |